Clinical Trials Directory

Trials / Completed

CompletedNCT02753868

Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Illinois at Urbana-Champaign · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effect of cycling at mild to moderate intensity during hemodialysis treatment on cardiovascular function in a crossover design.

Detailed description

Patients with kidney failure requiring hemodialysis (HD) treatment die at excessively high rates, despite advances in HD techniques and pharmacological therapies. This indicates additional therapeutic strategies are needed. Intradialytic exercise (IDEX, exercise during HD treatment) represents a low-cost, easy to administer treatment strategy that could potentially improve cardiovascular function, physical function and quality of life. However, nephrologists rarely counsel their patients to increase their physical activity levels or to exercise during HD treatment, in part due to a lack of understanding of IDEX knowledge. Providing more robust evidence for the safety and effectiveness of IDEX, as well as evaluating the impact of exercising early vs late in the treatment, could help improve adoption of exercise training as a standard practice in HD clinics. Therefore, investigators plan to examine the impact of IDEX and its timing during treatment (1st vs 3rd hour) on blood pressure and adverse symptoms in HD patients. The proposed study also includes various cardiovascular measures to allow deeper mechanistic understanding of cardiovascular physiology with IDEX. Such understanding will significantly advance the field and lead to improved therapeutic approaches, including exercise training, which may help mediate the deleterious effects of renal failure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALexerciseParticipants will be asked to cycle at mild to moderate intensity for 30 minutes during either 1-st hour of 3-rd hour into treatment
PROCEDUREHemodialysis treatmentParticipants will receive a standard hemodialysis treatment during the study period

Timeline

Start date
2016-02-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2016-04-28
Last updated
2017-03-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02753868. Inclusion in this directory is not an endorsement.